Pathologic response to neoadjuvant sequenced, lymphatic-sparing SBRT plus pembrolizumab in HPV-negative head and neck squamous cell carcinoma.

Authors: Richard Bryan Bell, Rom S. Leidner, Marka R. Crittenden, Kristina Hoot Young, Steven K. Seung, Ashish A. Patel, Hong Xiao, Matthew H. Taylor, Robert Hermann, Thomas Duhen, Brian Piening, Michael Gough, Bernard Fox, Douglas Hanes, Ezra Cohen, Andrew Sharabi, Robert Saddawi-Konefka, Liza Blumenfeld, J. Silvio Gutkind, Joseph A. Califano,

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.6084

Source: Full article

---

Abstract

6084